SCHEMBL3050371

SCHEMBL3050371

COc1cc2c(cc1OCc1ccccc1)CCN(Cc1ccccc1)C2

nearest known ligand 0.85

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
REV1 Q9UBZ9 1/20 0.84
CHRNA7 P36544 2/20 0.73
KMT2A Q03164 1/20 0.65
ABCB1 P08183 10/20 0.65
ABCC1 P33527 3/20 0.65
ABCG2 Q9UNQ0 2/20 0.65
KDM4E B2RXH2 3/20 0.60
GAA P10253 1/20 0.60
MAPT P10636 1/20 0.60
RAB9A P51151 1/20 0.60
TDP1 Q9NUW8 1/20 0.59
ALDH1A1 P00352 1/20 0.56
ALOX15 P16050 1/20 0.56
TSHR P16473 1/20 0.56
CASP1 P29466 1/20 0.56
CASP7 P55210 1/20 0.56
HSD17B10 Q99714 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3059193 0.94 REV1 (0.87) REV1CHRNA7KMT2AABCB1ABCC1
SCHEMBL3041638 0.93 REV1 (0.74) REV1CHRNA7KMT2AABCB1ABCC1
SCHEMBL3059243 0.93 REV1 (0.78) REV1CHRNA7KMT2AABCB1ABCC1
SCHEMBL3165278 0.93 REV1 (0.73) REV1CHRNA7KMT2AABCB1ABCC1
SCHEMBL3062442 0.92 REV1 (0.72) REV1CHRNA7KMT2AABCB1ABCC1
SCHEMBL3052241 0.92 REV1 (0.76) REV1CHRNA7KMT2AABCB1ABCC1
SCHEMBL3056974 0.91 REV1 (0.71) REV1CHRNA7KMT2AABCB1ABCC1
SCHEMBL3059849 0.91 REV1 (0.74) REV1CHRNA7KMT2AABCB1ABCC1
SCHEMBL3046416 0.91 REV1 (0.71) REV1CHRNA7KMT2AABCB1ABCC1
SCHEMBL8793776 0.91 REV1 (0.70) REV1CHRNA7KMT2AABCB1ABCC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100222299-A1 COMPOUND STERIX LIMITED (GB) 2010-09-02 US claimed
US-8394825-B2 Compound STERIX LIMITED (GB) 2013-03-12 US disclosed
US-8394825-B2 Compound STERIX LIMITED (GB) 2013-03-12 US disclosed
US-20100222299-A1 COMPOUND STERIX LIMITED (GB) 2010-09-02 US disclosed
US-20100222299-A1 COMPOUND STERIX LIMITED (GB) 2010-09-02 US disclosed
EP-2155192-A2 TETRAHYDROISOQUINOLINES AS TUMOUR GROWTH INHIBITORS Sterix Limited (GB) 2010-02-24 EP disclosed
WO-2008117061-A2 TETRAHYDROISOQUINOLINES AS TUMOUR GROWTH INHIBITORS STERIX LIMITED (GB) 2008-10-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100222299-A1 COMPOUND MKI67, VHL, MYC REV1 1520/4885CHRNA7 4760/4885KMT2A 924/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.